Outlook in 2017

Filter By:

Article Type
Year
  • Researchers delving into the details of bladder cancer are finding a rich trove of genetic information.

    • Jeanne Erdmann
    Outlook
  • Once thought to be sterile, the bladder contains microbes that could influence the development and treatment of cancer.

    • Claire Ainsworth
    Outlook
  • What happens when a professor of theatre finds out she has bladder cancer? She writes a one-woman play about it, of course.

    • Tammy Worth
    Outlook
  • Bladder cancer is more deadly in women than in men. That needs to change, say James McKiernan and Denise Asafu-Adjei.

    • James McKiernan
    • Denise Asafu-Adjei
    Outlook
  • Mechele Leon, an associate professor of theatre at the University of Kansas in Lawrence, was diagnosed with bladder cancer in March 2016. After treatment, Leon was left with no bladder, a urostomy bag, and a story to tell — which became a one-woman play called Bladder Interrupted.

    • Tammy Worth
    Outlook
  • People with metastatic bladder cancer once faced meagre treatment options and a grim prognosis. But immunotherapy has started to yield results.

    • Michael Eisenstein
    Outlook
  • Many non-invasive approaches to detecting bladder cancer are showing promise — including smart toilets.

    • Chelsea Wald
    Outlook
  • Conventional detection of advanced fatty liver disease relies on biopsy. Less onerous methods may help to save lives.

    • Michael Eisenstein
    Outlook
  • Not everyone with a fatty liver goes on to develop more advanced disease. Understanding what triggers the progression could lead to better treatments.

    • Sarah DeWeerdt
    Outlook
  • Biotechnology start-ups and pharmaceutical giants alike are charging ahead to develop therapies for the most serious form of non-alcoholic fatty liver disease.

    • Liam Drew
    Outlook
  • Let's start describing ALS on the basis of its cause, not on whether someone obtained a relevant family history, says Ammar Al-Chalabi.

    • Ammar Al-Chalabi
    Outlook